Adverum Biotechnologies I... (ADVM)
4.70
0.45 (10.59%)
At close: Jan 15, 2025, 3:59 PM
4.75
1.06%
After-hours Jan 15, 2025, 04:26 PM EST
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov 4, 2024
(Q3) AMC Q3 2024 | 7.30 | 7.41 | 7.54 | 7.53 | 7.77 | 7.26 | 7.72 | 7.94 | 7.90 | 8.00 | 7.89 | 7.76 | ||
IV: 1.08 RSI: 47 ADVM % | -7.36% | 1.51% | 1.51% | -0.13%
| 3.05%
| -3.71%
| 2.39%
| 2.85% | -0.50% | 1.27% | 1.68% | -2.02% | ||
Aug 12, 2024
(Q2) AMC Q2 2024 | 6.92 | 6.56 | 6.49 | 6.55 | 7.02 | 6.55 | 6.76 | 6.45 | 6.53 | 6.82 | 6.91 | 6.70 | ||
IV: 1.15 RSI: 35 ADVM % | 2.52% | -5.20% | -5.20% | 0.92%
| 8.17%
| 0.92%
| 4.16%
| -4.59% | 1.24% | 4.44% | -4.69% | -0.30% | ||
Aug 5, 2021
(Q2) AMC Q2 2021 | 23.60 | 23.20 | 24.10 | 23.60 | 25.90 | 23.20 | 24.80 | 25.40 | 24.90 | 24.60 | 23.40 | 22.70 | ||
IV: - RSI: 32 ADVM % | -0.84% | -1.69% | -1.69% | -2.07%
| 7.47%
| -3.73%
| 2.90%
| 2.42% | -1.97% | -1.20% | -4.49% | -4.62% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.